DC Investments Management’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.6K | Hold |
35,563
| – | – | 0.02% | 104 |
|
|
2025
Q1 | $49.1K | Hold |
35,563
| – | – | 0.03% | 110 |
|
|
2024
Q4 | $108K | Hold |
35,563
| – | – | 0.07% | 89 |
|
|
2024
Q3 | $177K | Hold |
35,563
| – | – | 0.12% | 84 |
|
|
2024
Q2 | $208K | Hold |
35,563
| – | – | 0.18% | 80 |
|
|
2024
Q1 | $282K | Hold |
35,563
| – | – | 0.23% | 83 |
|
|
2023
Q4 | $207K | Hold |
35,563
| – | – | 0.21% | 72 |
|
|
2023
Q3 | $91K | Hold |
35,563
| – | – | 0.11% | 83 |
|
|
2023
Q2 | $88.9K | Hold |
35,563
| – | – | 0.1% | 81 |
|
|
2023
Q1 | $74.7K | Hold |
35,563
| – | – | 0.09% | 82 |
|
|
2022
Q4 | $55.1K | Hold |
35,563
| – | – | 0.07% | 58 |
|
|
2022
Q3 | $110K | Hold |
35,563
| – | – | 0.25% | 27 |
|
|
2022
Q2 | $112K | Hold |
35,563
| – | – | 0.25% | 36 |
|
|
2022
Q1 | $100K | Hold |
35,563
| – | – | 0.17% | 46 |
|
|
2021
Q4 | $160K | Hold |
35,563
| – | – | 0.23% | 54 |
|
|
2021
Q3 | $297K | Buy |
+35,563
| New | +$297K | 0.55% | 41 |
|